COVID19 vaccine.docx - Name 1 Name Professor Class...

This preview shows page 1 - 2 out of 4 pages.

Name 1NameProfessorClass InformationDate The Race for COVID-19 VaccineOver 270,000 deaths across the globe—with 79,000 and counting in the United States—have spurred on a frenetic race to find a cure for the novel coronavirus. Due to the extremely pernicious nature of the COVID-10 pandemic, drug companies are knee-deep in that race to development a COVID-19 vaccine in a celeritous fashion. Unfortunately, these companies face herculean challenges with their clinical trials, government facilitation and approval, and their production capacity (Xie, 2020). Beyond needing to stop the escalating death toll, there are trillion dollars at stake in producing that vaccine, which is why these companies are competing tobe the first as a means for countries to enhance their global influence while also restoring battered economies. Nonetheless, the world continues to pin its hopes that an efficacious vaccine will be produced to prevent any further spread or deaths by the deadly virus. Until a vaccine has

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture